- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS
THERETO FILED PURSUANT TO RULE 13d-2(a)
(Amendment No. )1
ENTREMED, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.01 PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
29382F103
- --------------------------------------------------------------------------------
(CUSIP Number)
GEORGE R. WHITTEMORE, MILLS VALUE ADVISER, INC.,
707 EAST MAIN STREET, RICHMOND, VIRGINIA 23219 (804) 344-3804
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
January 11, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box |_|.
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for
other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 6 Pages)
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934, as amended (the "Act"), or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
- --------------------------------------------------------------------------------
<PAGE>
- ---------------------------- ----------------------------
CUSIP No. 29382F103 SCHEDULE 13D Page 2 of 6 Pages
- ---------------------------- ----------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
James T. Martin
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
Not Applicable
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e) |_|
Not Applicable
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 625,090
-------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
-0-
-------------------------------------------------------
OWNED BY EACH 9 SOLE DISPOSITIVE POWER
REPORTING 625,090
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON WITH
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
625,090
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
|_|
Not Applicable
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.0%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
SCHEDULE 13D
FOR
JAMES T. MARTIN
Item 1. Security and Issuer
This statement relates to the common stock, par value $0.01 per
share ("Common Stock"), of EntreMed, Inc., 9610 Medical Center
Drive, Suite 200, Rockville, Maryland 20850 (the "Issuer").
Item 2. Identity and Background
(A) James T. Martin
(B) Tuppeny House
Tuckerstown, Bermuda
(C) James T. Martin is a lecturer, author and consultant.
(D) During the past five years, James T. Martin has not been
convicted in a criminal proceeding, excluding traffic
violations or similar misdemeanors.
(E) During the past five years, James T. Martin has not been a
party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and has not
been subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state
securities laws or finding any violation with respect to
such laws.
(F) James T. Martin is a citizen of Bermuda (subject of Great
Britain).
Item 3. Source and Amount of Funds and Other Consideration
The total amount of the funds used in making the purchases was
$17,011,647. The sources of the funds used in making the purchases
were personal funds.
Page 3 of 6 Pages
<PAGE>
Item 4. Purpose of Transaction
James T. Martin has purchased shares of Common Stock for
investment purposes.
There are no plans or proposals which James T. Martin may have
that relate to or would result in:
(A) The acquisition by any person of additional securities of
the Issuer, or the disposition of securities of the
Issuer, except as otherwise disclosed herein;
(B) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any
of its subsidiaries;
(C) A sale or transfer of a material amount of assets of the
Issuer or of any of its subsidiaries;
(D) Any change in the present board of directors or management
of the Issuer, including any plans or proposals to change
the number or term of directors or to fill any existing
vacancies on the board;
(E) Any material change in the present capitalization or
dividend policy of the Issuer;
(F) Any other material change in the Issuer's business or
corporate structure;
(G) Changes in the Issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede
the acquisition of control of the Issuer by any person;
(H) Causing a class of securities of the Issuer to be delisted
from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation
system of a registered national securities association;
(I) A class of equity securities of the Issuer becoming
eligible for termination of registration pursuant to
Section 12(g)(4) of the Securities Exchange Act of 1934,
as amended; or
(J) Any action similar to any of those enumerated above.
Page 4 of 6 Pages
<PAGE>
Item 5. Interest in Securities of the Issuer
(A) The aggregate number and percentage of Common Stock
beneficially owned by James T. Martin are 625,090 Shares
and 5.0%, respectively.
(B) James T. Martin has the sole power to vote or to direct
the vote of all the shares identified pursuant to Item
5(a). Mr. Martin does not have any power to dispose or to
direct the disposition of all the shares identified
pursuant to Item 5(a).
(C) Transactions in the securities identified pursuant to Item
5(a) during the past 60 days are as follows:
Beneficial Trans. Amount of Price Per Where/How
Owner Date Transaction Share Effected
J.T. Martin 11/16/98 $360,626 $24.04 Open Market
J.T. Martin 11/17/98 $232,877 $23.28 Open Market
J.T. Martin 11/19/98 $240,356 $24.03 Open Market
J.T. Martin 11/27/98 $480,960 $25.31 Open Market
J.T. Martin 12/03/98 $244,312 $24.43 Open Market
J.T. Martin 12/04/98 $1,251,751 $25.03 Open Market
J.T. Martin 12/08/98 $248,851 $24.88 Open Market
J.T. Martin 12/14/98 $239,351 $23.93 Open Market
J.T. Martin 12/15/98 $240,601 $24.06 Open Market
J.T. Martin 12/21/98 $233,101 $23.31 Open Market
J.T. Martin 12/24/98 $235,231 $23.52 Open Market
J.T. Martin 01/04/99 $219,291 $21.92 Open Market
J.T. Martin 01/11/99 $252,671 $25.26 Open Market
(D) Not applicable.
(E) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer
None
Item 7. Material to be Filed as Exhibits
None
Page 5 of 6 Pages
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement on Schedule 13D is
true, complete and correct.
James T. Martin
Date: January 11, 1999 /s/ James T. Martin
-----------------------------------
James T. Martin
Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
